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Abstract
The discrete modeling formalism of Rene ´ Thomas is a well known approach for the modeling and analysis of Biological
Regulatory Networks (BRNs). This formalism uses a set of parameters which reflect the dynamics of the BRN under study.
These parameters are initially unknown but may be deduced from the appropriately chosen observed dynamics of a BRN.
The discrete model can be further enriched by using the model checking tool HyTech along with delay parameters. This
paves the way to accurately analyse a BRN and to make predictions about critical trajectories which lead to a normal or
diseased response. In this paper, we apply the formal discrete and hybrid (discrete and continuous) modeling approaches to
characterize behavior of the BRN associated with MyD88-adapter-like (MAL) – a key protein involved with innate immune
response to infections. In order to demonstrate the practical effectiveness of our current work, different trajectories and
corresponding conditions that may lead to the development of cerebral malaria (CM) are identified. Our results suggest that
the system converges towards hyperinflammation if Bruton’s tyrosine kinase (BTK) remains constitutively active along with
pre-existing high cytokine levels which may play an important role in CM pathogenesis.
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Introduction
Severe forms of malaria claim a huge number of lives
worldwide, contributing to over a million deaths annually, mostly
that of children [1]. Malaria is vectored by Anopheles mosquitoes
and is a common infectious disease caused by Plasmodium
parasites that readily infect blood erythrocytes [2]. In a few cases a
severe pathogenesis occurs due to hyperinflammation, usually
following Plasmodium falciparum infection, that may turn fatal.
The blood flow through small blood vessels to the brain is severely
hampered as the infected erythrocytes are sequestered by parasites
causing ischaemic hypoxia and increased nitric oxide production
in brain tissues, leading to coma, a condition known as diffuse
encephalopathy or CM [3–5]. Clinical prognosis depends on
factors ranging from patient’s social conditions to recurrent
parasitic exposure, however current evidence strongly suggests
that the genetics of an individual may play an even more
significant role [6–8].
The human innate immune system is the first line of defence
against such infections and the responses include inflammation
which helps to control the infection and promotes healing. Yet if
left unchecked, this advantageous inflammatory response turns
astray, causing effects ranging from mild allergies to severe
inflammatory disorders [9]. Acute inflammatory response is
initiated following an infection through the production of
proinflammatory cytokines, such as the tumor necrosis factor
alpha (TNF-a) and the interferon gamma (INF-c) that play a
prominent role in parasite destruction. The generation of
inflammation is tightly regulated at multiple levels to control this
production. However, in cases where pathogenesis becomes
severe, chronic over production of cytokines contributes to
elevated levels of a cellular messenger, induced nitric oxide
synthase (iNOS). These elevated levels of iNOS plus the hypoxia
caused by the parasites work in sync to create a condition of
chronic hyperinflammation causing an augmentation of CM
pathogenesis [3,10].
The signal transduction pathway involved in systemic produc-
tion of proinflammatory cytokines in case of malaria is initiated
following the activation of the Toll like receptor 2 (TLR2) and
TLR4 when they recognize glycosylphosphatidylinositols (GPIs)
anchored on plasmodium membrane proteins [11–13]. TLRs are
characteristic type I transmembrane pattern recognition receptors,
used by the innate immune system to recognize conserved
microbial structures or pathogen-associated molecular patterns
(PAMPs). They have a conserved cytoplasmic toll-interleukin 1
receptor (TIR) domain and are included in the interleukin 1
receptor (IL-1R)/TLR super-family [14]. After stimulation by
PAMPs, TLRs form dimers and begin an intricate multifaceted
signalling cascade, initiated by the recruitment of adapter proteins
at their cytoplasmic TIR domain. The myeloid differentiation
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33532primary response protein (MyD88) and a number of kinases (like
interleukin-1 receptor-associated kinases; IRAKs) are recruited
downstream. The signal transduction culminates with the activation
of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-
kB), resulting in the expression of proinflammatory cytokine genes
(see Figure 1) . For details of the TLR signalling see reference [15].
Khor et al. and others [8,16–18] indicate the toll-interleukin 1
receptor domain containing adapter protein (TIRAP), also known
as MyD88-adapter-like (MAL), as a key adapter protein associated
with disease pathogenesis leading to hyperinflammation. They
argue on the basis of single nucleotide polymorphism (SNP)
analysis that wild-type MAL may lead to chronic hyperinflamma-
Figure 1. TLR2/4 signalling pathway. The TLR2/4 signalling pathway starts with recognition (1) of PAMPs by TLRs. This activates (2) BTK which
phosphorylates (3) MAL. MyD88 adapter protein and kinases are recruited (4) and activated around MAL. This eventually leads to the activation (5) of
NF-kBa sI kB is degraded. The proinflammatory cytokine genes are expressed (6) producing INCY that are secreted (7). INCY are responsible (8) for the
production of inflammation and activation of their respective receptors. This again activates NF-k B (9a) and through an alternate pathway induces
the production of SOCS-1 (9b). SOCS-1 negatively regulates MAL by polyubiquitination (10a) and blocks NF-k B mediated expression (10b).
Abbreviations: TLR, toll like receptors; PAMPs, pathogen associated molecular patterns; BTK, bruton’s tyrosine kinase; MAL, MyD88 adapter like;
MyD88, myeloid differentiation response protein; NF-kB, nuclear factor kappa-light-chain-enhancer of activated B cells; IkB, inhibitor of kB; INCY,
proinflammatory cytokines; SOCS-1, suppressor of cytokine signaling-1 [15,24,25].
doi:10.1371/journal.pone.0033532.g001
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mutants may confer a protective effect from CM pathogenesis for
its carrier host by controlling the amount of inflammation
produced. Some studies have suggested MAL as an important
therapeutic target for the management of CM pathogenesis [19–
21].
Signalling regulators associated with MAL include Bruton’s
tyrosine kinase (BTK) which is a member of the Tec family of
kinases. It acts as a positive regulator of MAL by activating it
through phosphorylation [22,23]. The inflammatory cytokines
(INCY) produced not only generate inflammation but also induce
SOCS-1 (suppressor of cytokine signaling-1), which degrades
phosphorylated MAL through polyubiquitination. It is also known
to block NF-kB mediated expression, thereby functioning as a
negative regulator for this signalling pathway [24,25].
A biological regulatory network (BRN) is a set of interactions
(activation and inhibition) between biological entities (e.g., proteins
in a biological signalling network). The MAL associated BRN
(Figure 2) was abstracted from the TLR2/4 signalling pathway
(Figure 1) and includes: BTK that activates MAL through
phosphorylation; SOCS-1 that degrades phosphorylated MAL
by polyubiquitination; NF-kB which is the key transcription factor
for initiating the expression of proinflammatory genes; and the
INCY which produce the inflammation.
Two tools, GENOTECH [26] and HyTech [27], were used for
the modeling and analysis of this BRN. In GENOTECH tool the
qualitative modeling formalism of Rene ´ Thomas [28–36] has been
implemented. A BRN in GENOTECH is represented by a
directed graph where nodes represent biological entities and edges
represent interactions among them. The edges are labeled with
integers representing concentration thresholds and signs of
interactions (+for activation and 2for inhibition). Each entity is
assigned a set of logical parameters to generate a state graph
(qualitative model) reflecting the possible steady state behaviors of
the BRN. GENOTECH also generates a hybrid model by
incorporating clocks that measure activation and degradation
delays. This hybrid model is analyzed by HyTech which is a tool
for the analysis of hybrid systems [37] to compute parametric
constraints for the existence of a particular behavior.
This study uses qualitative discrete and hybrid modeling with
delays to model the MAL associated BRN. The model
characterizes conditions when the system may converge toward
hyperinflammation. Initially, a discrete qualitative modeling of the
BRN was done to predict qualitative behaviors or states which
either lead to a normal (normal inflammatory) or diseased
(hyperinflammatory) state. The qualitative model was then refined
with clocks measuring regulation delays to obtain a hybrid model
incorporating discrete and continuous behaviors. Our results
suggest that the system converges towards hyperinflammation
when concentration of cytokines is at high level. Furthermore, we
obtained the conditions for each behavior of the MAL associated
BRN in terms of delay constraints in order to select consistent
models regarding delays (see HyTech results for delay constraints).
These results give useful information such as, which variable is
evolving with high production or degradation rate in order to
follow a particular behavior or path. The delay constraints further
suggest that for some given set of delay values, the behaviors (see
Discussion section) would be very stable and for other set of values
they would not exist.
In summary, we make use of qualitative in-silico modeling; a
kind of computational method [38] used in systems biology, to
characterize the behaviors of MAL associated BRN. At the same
time we follow the trend in systems biology [39] to augment the
descriptive and analytical power of models in systems biology by
formal methods.
Results
This section presents the results obtained by using the modeling
and analysis tools for the MAL associated BRN (Figure 2). The
first subsection describes the results obtained by the qualitative
modeling and analysis of the BRN using the GENOTECH tool
[26]. The results obtained by using the HyTech [27] tool for the
hybrid modeling and analysis of the BRN are given in the second
subsection.
The State Graph of the MAL associated BRN
GENOTECH is a tool for the qualitative (discrete) modeling of
BRNs according to Thomas’ formalism (see methods). It takes a
BRN and corresponding logical parameters from a user in a
simple graphical user interface (GUI) and then automatically
generates the state graph in which stable states, cycles and paths
between any two states can be identified. GENOTECH generates
the state graph (qualitative model) of the MAL associated BRN
(Figure 2) representing all possible transitions from one state to the
other (Figure 3), where each state indicates the concentrations of
every entity at a particular time. A state is represented by BTK,
MAL, NF-kB, INCY and SOCS-1, in the respective order. In a
stable state, the whole system converges, halts and cannot proceed
to any other state. The stable states are called sinks and the
network from any initial state either moves towards these sinks, or
ends up in a cyclic path if there is a cycle in the network. From any
state other than the stable states, a path that leads to and
culminates at a sink is called a trajectory; and all trajectories
culminate at some sink or remain in a cycle. It is an inherent
property of any system to attain stability; therefore whenever the
system is perturbed from its stable state or sink, it tends to shift
back or reach another stable state. For the functional and realistic
Figure 2. MAL associated BRN. Numerals (1 and 2) represent the
threshold levels of interactions; plus (+) signs indicate activation while
inactivation is indicated by a minus (2) sign. Arrows indicate the
direction of activation/inactivation. The thresholds values are set
according to Definition 2.
doi:10.1371/journal.pone.0033532.g002
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state where every component has a zero concentration is
imperative as this state represents the system before any
perturbation ( also called the virgin state).
In our case two stable states (also called stable steady states or
sinks) are produced, indicating zero concentrations for every
component (0,0,0,0,0) in the first state; and zero concentration for
BTK and MAL, 1 for NF-kB, 2 for INCY and 1 for SOCS-1
(0,0,1,2,1) in the second state. The stable state (0,0,0,0,0)
represents the normal behavior where infection is cleared whereas
(0,0,1,2,1) represents the diseased behavior leading to hyperin-
flammation. Since BTK is the initiator for this BRN, the state
(1,0,0,0,0) was taken as the starting state. All possible trajectories
from this starting state leading to the normal and diseased states
were identified (Figure 4). The trajectories leading to the sink
(0,0,0,0,0) are representatives of a normal behavior against
infection, where inflammation is produced to clear the infection
and diminished afterwards.
HyTech Results for Delay Constraints
All possible transitions of normal (towards (0,0,0,0,0)) and
divergent (towards (0,0,1,2,1) pathways are highlighted in Figure 4
and the corresponding conditions are listed in Table 1. The state
(1,0,0,0,0) is the initial state of the hybrid model. There are two
Figure 3. State graph of the MAL associated BRN. The complete state graph is obtained by using the GENOTECH tool. Definitions 2 and 4 assist
in setting the values of the K-parameters. The K-parameters are set such that they result in a model coherent with the observed steady states behaviors.I nt h e
case of MAL-associated BRN these states are (0,0,0,0,0) and (0,0,1,2,1). In the state (0,0,0,0,0) the system does nothing when there is no signal of pathogen or
returns to this state after proper response. In the state (0,0,1,2,1), the system produces inflammation continuously. The set of logical parameters is:
KBTK(fg)~0, KMAL(fg)~0, KMAL(fSOCS{1g)~0, KMAL(fBTKg)~1, KMAL(fBTK,SOCS{1g)~1, KNF{kB(fg)~0, KNF{kB(fSOCS{1g)~0,
KNF{kB(fINCYg)~1, KNF{kB(fMALg)~1, KNF{kB(fINCY,SOCS{1g)~1, KNF{kB(fMAL,INCYg)~1, KNF{kB(fMAL,SOCS{1g)~1,
KNF{kB(fMAL,INCY,SOCS{1g)~1, KINCY(fg)~0, KINCY(fNF{kBg)~2, KSOCS{1(fg)~0 and KSOCS{1(fINCYg)~1.
doi:10.1371/journal.pone.0033532.g003
Figure 4. Normal and Divergent paths. Each circle represents a particular state (configuration) and inside the circle the values 0,1 and 2
represent qualitative levels of proteins according to the order (BTK, MAL, NF-kB, INCY, SOCS-1). The solid lines show the transition which leads to
normal state (0,0,0,0,0) and the dotted lines show the transitions towards the state of hyperinflammation (0,0,1,2,1). The conditions for all the
transitions in this figure are given in Table 1.
doi:10.1371/journal.pone.0033532.g004
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(1,1,0,0,0) from the initial state. The constraint d
z
MAL§d
{
BTK
shows that if the deactivation (or degradation) delay of BTK is less
than or equal to the activation delay of MAL, then the next
location of the system will be (0,0,0,0,0), which is a stable state
representing normal behavior. The transition (1,0,0,0,0)?
(1,1,0,0,0) (Figure 4 and Table 1 - Transition 1) can only occur
if the positive delay of MAL (d
z
MAL) is less than or equal to the
degradation delay of BTK (d
{
BTK), i.e. if the rate of activation of
MAL is faster than the rate of degradation of BTK. The transition
(1,1,0,0,0)?(0,1,0,0,0) can only occur if the sum of the activation
delays of MAL and NF-kB will be greater than or equal to the
degradation delay of BTK (see transition 2 in Table 1). The
transition (0,1,0,0,0)?(0,1,1,0,0) will occur unconditionally
because there is only one outer transition from state (0,1,0,0,0)
and this will occur after some delay (d
z
NFkB) which is needed to
activate NF{kB. The transitions which lead to divergence from
normal pathways (shown as dotted lines in Figure 4) are important
because these can provide useful information about the BRN
dynamics. The state (0,1,1,1,0) has two transitions, one towards a
normal and the other towards a divergent path (see Figure 4,
transitions 5 and 15). The transition (0,1,1,1,0)?(0,1,1,1,1) is
only possible if SOCS-1 becomes active before the cytokines
reaches level 2 (INCY2). If this is not the case, then the net-
work will be in state (0,1,1,2,0), which ultimately leads to the
diseased state (0,0,1,2,1). Another very sensitive transition is
(0,0,1,1,1)?(0,0,1,2,1), which directly leads into a diseased state
due to the high level of cytokines (level 2). In order to follow a
particular path all conditions (see Table 1) of individual transitions
must be satisfied. The conditions for all paths leading to the stable
states are given in Table 1 and 2 respectively. All the constraints of
Table 1 and 2 were computed in 0:24 seconds on Intel Core i7
machine.
Discussion
MAL is imperative for TLR2/4 downstream signaling, acting
both as an adapter sorter by bringing in other adapter proteins to
the TLR cytoplasmic TIR domain. It also acts as a site for the
assembly of several kinases important for downstream signal
transduction leading to inflammation. Although production of
inflammation in response to infection is not just limited to the TLR
Table 1. Delay constraints for transitions.
Transition number Transitions Conditions for the transitions
1 10000?11000 d
z
MALƒd
{
BTK
2 11000?01000 d
{
BTKƒd
z
MALzd
z
NFkB
3 01000?01100 d
z
NFkB§0
4 01100?01110 d
z
INCY§0
5 01110?01111 d
z
SOCSƒd
z
INCY2
6 01111?00111 d
{
MALzd
z
SOCS{1ƒd
z
INCY2
7 00111?00011 d
{
MALzd
{
NFkBzd
z
SOCS{1ƒd
z
INCY2
8 00011?00001 d
{
INCY§0
9 00001?00000 d
{
SOCS{1§0
10 11000?11100 d
z
MALzd
z
NFkBƒd
{
BTK
11 11100?01100 d
{
BTKƒd
z
MALzd
z
NFkBzd
z
INCY
12 11100?11110 d
z
MALzd
z
NFkBzd
z
INCYƒd
{
BTK
13 11110?01110 d
{
BTK§d
z
MALzd
z
NFkBzd
z
INCYzd
z
SOCS{1
14 11110?11111 d
z
SOCS{1ƒd
z
INCY2
15 11111?01111 d
{
BTKƒd
z
MALzd
z
NFkBzd
z
INCYzd
z
INCY2
16 11110?11120 d
z
INCY2ƒd
z
SOCS{1
17 11120?01120 d
z
MALzd
z
NFkBzd
z
INCYzd
z
SOCS{1ƒd
{
BTK
18 11121?01121 d
{
BTK§0
19 01121?00121 d
{
MAL§0
20 11120?11121 d
z
MALzd
z
NFkBzd
z
INCYzd
z
INCY2ƒd
{
BTK
21 01120?01121 d
z
SOCS{1§0
22 11111?11121 d
{
BTK§d
z
MALzd
z
NFkBzd
z
INCYzd
z
INCY2
23 01110?01120 d
z
INCY2ƒd
z
SOCS{1
24 00111?00121 d
{
MALzd
{
NFkBzd
z
SOCS{1§d
z
INCY2
25 10000?00000 d
z
MAL§d
{
BTK
26 01111?01121 d
z
INCY2ƒd
{
MALzd
z
SOCS{1
The delay constraints of all paths starting from state (10000) are automatically generated by HyTech. Constraints related to paths identified (Figure 10) are arranged in
tabular form as shown in Table 2. d
z
i (resp. d
{
i ) is the delay for the evolution of a protein i from level 0 to 1 (resp. from level 1 to 0). Similarly, d
z
i2 (resp. d
{
i2 ) is the delay
for the evolution of a protein i from level 1 to 2 (resp. from level 2 to 1).
doi:10.1371/journal.pone.0033532.t001
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putative role of MAL in the pathogenesis of CM due to
hyperinflammation [8,16–18]. In this study we use discrete
qualitative and hybrid modeling with delay constraints to
characterize the behavior of MAL associated BRN.
Discrete Modeling
A qualitative discrete model based on the kinetic logic of
Thomas is obtained using GENOTECH by providing it
information of component interactions and their respective
threshold concentration levels. The GENOTECH results are
Table 2. Delay constraints for paths.
10000?00000:d
z
MAL§d
{
BTK
10000?11000?01000?01100?01110?01111?00111?00011?0001?00000:
(d
z
MALƒd
{
BTK)^ (d
{
BTKƒd
z
MALzd
z
NFkB)^ (d
z
NFkB§0)^ (d
z
INCY§0)
^ (d
z
SOCS{1ƒd
z
INCY2)^ d
{
MALzd
z
SOCS{1ƒd
z
INCY2
^ (d
{
MALzd
{
NFkBzd
z
SOCS{1ƒd
z
INCY2)^ (d
{
INCY§0)^ (d
{
SOCS{1§0)
10000?11000?11100?01100?01110?01111?00111?00011?0001?00000:
(d
z
MALƒd
{
BTK)^ (d
z
MALzd
z
NFkBƒd
{
BTK)^ (d
{
BTKƒd
z
MALzd
z
NFkBzd
z
INCY)
^ (d
z
INCY§0)^ (d
z
SOCS{1ƒd
z
INCY2)^ d
{
MALzd
z
SOCS{1ƒd
z
INCY2
^ (d
{
MALzd
{
NFkBzd
z
SOCS{1ƒd
z
INCY2)^
(d
{
INCY§0)^ (d
{
SOCS{1§0)
10000?11000?11100?11110?01110?01111?00111?00011?0001?00000:
(d
z
MALƒd
{
BTK)^ (d
z
MALzd
z
NFkBƒd
{
BTK)^ (d
z
MALzd
z
NFkBzd
z
INCYƒd
{
BTK)
^ ((d
{
BTKƒd
z
SOCS{1)^ (d
{
BTKƒd
z
INCY2))^ (d
z
SOCS{1ƒd
z
INCY2)
^ d
{
MALzd
z
SOCS{1ƒd
z
INCY2
(d
{
MALzd
{
NFkBzd
z
SOCS{1ƒd
z
INCY2)^ (d
{
INCY§0)^ (d
{
SOCS{1§0)
10000?11000?11100?11110?11111?01111?00111?00011?0001?00000:
(d
z
MALƒd
{
BTK)^ (d
z
MALzd
z
NFkBƒd
{
BTK)^ (d
z
MALzd
z
NFkBzd
z
INCYƒd
{
BTK)
^ (d
z
SOCS{1ƒd
z
INCY2)^ (d
{
BTKƒd
z
MALzd
z
NFkBzd
z
INCYzd
z
INCY2)
^ d
{
MALzd
z
SOCS{1ƒd
z
INCY2 ^ (d
{
MALzd
{
NFkBzd
z
SOCS{1ƒd
z
INCY2)
^ (d
{
INCY§0^ d
{
SOCS{1§0)
10000?11000?01000?01100?01110?01111?00111?00121:
(d
z
MAL§d
{
BTK)^ (d
{
BTKƒd
z
MALzd
z
NFkB)^ (d
z
NFkB§0)^ (d
z
SOCS{1ƒd
z
INCY2)
^ d
{
MALzd
z
SOCS{1ƒd
z
INCY2 ^ (d
z
INCY2ƒd
{
NFkB)
10000?11000?01000?01100?01110?01120?01121?00121:
(d
z
MAL§d
{
BTK)^ (d
{
BTKƒd
z
MALzd
z
NFkB)^ (d
z
NFkB§0)^ (d
z
SOCS{1ƒd
z
INCY2)
^ (d
z
INCY2ƒd
z
SOCS{1)^ (d
{
SOCS{1§0)^ (d
{
MAL§0)
10000?11000?11100?11110?11120?11121?01121?00121:
(d
z
MALƒd
{
BTK)^ (d
z
MALzd
z
NFkBƒd
{
BTK)^ (d
{
BTKƒd
z
MALzd
z
NFkBzd
z
INCY)
^( d
z
INCY§0)^ (d
z
INCY2ƒd
z
SOCS{1)^ (d
z
MALzd
z
NFkBzd
z
INCYzd
z
INCY2ƒd
{
BTK)
^ (d
{
BTK§0)^ (d
{
MAL§0)
10000?11000?11100?11110?11120?01120?01121?00121:
(d
z
MALƒd
{
BTK)^ (d
z
MALzd
z
NFkBƒd
{
BTK)^ (d
{
BTKƒd
z
MALzd
z
NFkBzd
z
INCY)
^ (d
z
INCY§0)^ (d
z
MALzd
z
NFkBzd
z
INCYzd
z
SOCS{1ƒd
{
BTK)
^ (d
z
SOCS{1§0)^ (d
{
MAL§0)
10000?11000?11100?11110?11111?11121?01121?00121:
(d
z
MALƒd
{
BTK)^ (d
z
MALzd
z
NFkBƒd
{
BTK)
^ (d
z
MALzd
z
NFkBzd
z
INCYƒd
{
BTK)
^ (d
z
SOCS{1ƒd
z
INCY2)^ (d
{
BTK§d
z
INCY2)^ (d
{
BTK§0)^ (d
{
MAL§0)
Delay constraints for the normal and diverging paths of Figure 10. All paths ending with the state (0000) are normal while others ending with (00121) are divergent. The
symbol ^ is the conjunction operator. d
z
i (resp. d
{
i ) is the delay for the evolution of a protein i from level 0 to 1 (resp. from level 1 to 0). Similarly, d
z
i2 (resp. d
{
i2 )i st h e
delay for the evolution of a protein i from level 1 to 2 (resp. from level 2 to 1).
doi:10.1371/journal.pone.0033532.t002
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MAL state space from here on and it represents different
configurations the system may reside in as an inflammatory
response is initiated. The two stable states or sinks generated
indicate two distinct behaviors for the system, parallel to the
normal and diseased behaviors, and any configuration of the
system may eventually move toward either of these two sinks
through specific trajectories or paths (Figure 3 and 4). These two
states are (0,0,0,0,0), indicating zero concentration for every
component; and (0,0,1,2,1), indicating zero concentration for
BTK and MAL, one for NF-kB, two for INCY and one for
SOCS-1 respectively. The sink (0,0,0,0,0) represents the normal
behavior where inflammation is produced in response to infection
and the system reverts to this resting state after mounting an
inflammatory response. In contrast, the sink (0,0,1,2,1) represents
a diseased behavior where INCY levels are very high and a
condition of hyperinflammation is produced. MAL state space
allows for transitions between different states forming trajectories
or paths that lead toward either the (0,0,0,0,0) or the (0,0,1,2,1)
sink and the significance of these transitions is that they represent
the indigenous ability of the system to attain stability.
The complete state space is very large and it becomes important
to isolate key trajectories that lead either to a normal or diseased
sink. The shortest possible route toward the normal sink was
identified and used as the reference trajectory (Figure 4). Small
divergences from this trajectory that culminate at the normal state
were also identified. Other critical divergences were those that lead
to the diseased state and these present the perturbations the system
may encounter. Divergences that eventually lead to the normal
state indicate perturbations that the system can tolerate, while
divergences that can only lead to the diseased state are
perturbations that put too much stress on the system resulting in
a collapse of the system controls.
This MAL state space suggests that the system maintains the
capacity to stabilize itself after perturbations as long as the
concentration of INCY for any particular state within the system
remains at level 1. But once the concentration of INCY attains
level 2, the system enters trajectories that lead only to the sink
(0,0,1,2,1), representing the diseased behavior. It is important to
note that the threshold concentration level for INCY for the
diseased state is 2. This indication is supported by the
experimental observations made in the case of bacterial sepsis
where the pathogenesis is associated with the over production of
INCY and hyperinflammation [40,41]. The pathogenesis and
tissue injury in case of sepsis is closely related to the severe malarial
pathogenesis [42].
Another important indication is that the moment INCY
appears, the system is at risk of entering trajectories that may
only lead to the diseased state (Figure 4, transitions 23 and 24). For
the normal trajectory the INCY concentration level is maintained
at 1, however when concentration level of 2 for INCY is acquired,
the system loses its capacity to revert toward normality and moves
towards the diseased state in a progressive manner. Furthermore,
since INCY are produced through several alternate pathways, the
Figure 5. Activation and degradation of entities. (A.) Sigmoidal (above) and Step function (below) representation of activation. (B.) Sigmoidal
(above) and Step function (below) representation of degradation (inhibition).
doi:10.1371/journal.pone.0033532.g005
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other reason, like prior inflammatory condition, the chance of the
system shifting towards diseased state elevates. The state (0,0,1,1,1)
is indicative of this where it culminates directly at the diseased state
with only one transition (Figure 4, transition 24). Moreover, the
model also indicates that an important component for this BRN
(apart from MAL) is BTK which remains constitutively active in the
cases where the divergence from the normal trajectory leads to the
diseased state (Figure 4, for example the trajectory with transitions
1, 10, 12, 14, 22, 18 and 19). BTK is important for activation of
MAL through phosphorylation, and this suggests that BTK may
also play an important role in pushing the system towards
hyperinflammation, and warrants further investigation.
Hybrid Modeling
The rate at which a component of a BRN is regulated in
relation to other components determines the direction of the
evolution of the system. These rates are proportional to the
threshold concentrations for each component and are modeled as
unvalued parameters with delays. HyTech [27] uses these delays
as unvalued parameters along with the discrete model of our BRN
to calculate the conditions, in the form of constraints that are
required for a transition between two states to occur. A path in the
model is a sequence of states leading to a particular stable steady
state and HyTech synthesizes the conditions for transitions
between the states (Table 1). The conjunctions of all the
constraints of the path constitute the conditions for that path to
be followed (Table 2). Only when these conditions are satisfied, the
system will reach a stable state representing either normal or
diseased behavior.
(1,1,1,1,0) ? (1,1,1,2,0) & (0,1,1,1,0) ? (0,1,1,2,0) (transitions
16 & 23): These transitions require that the rate of production of
INCY in order to reach high level (level 2) should be faster than
the induction of SOCS-1, suggesting that reducing high cytokine
levels and inducing SOCS-1 can help to avoid this transition.
(1,1,1,1,1) ? (1,1,1,2,1) (transition 22): The conditions for this
transition suggest that if BTK remains active for a long period of
time, the system will lead to the diseased state. This can be due to
continuous activation of MAL by BTK and adapting strategies to
prevent this is suggested.
(0,1,1,1,1) ? (0,1,1,2,1) & (0,0,1,1,1) ? (0,0,1,2,1) (transitions
26 & 24): These transitions suggests that the system may also move
towards diseased state due to multiple factors being involved that
include: high rate of production of INCY; slow rate of deactivation
of MAL, induction of SOCS-1, and deactivation of NF-kB. To
avoid these transitions, intervention at multiple levels is suggested
that include: reducing high cytokine levels, NF-kB and their
effects; faster rate of deactivation of MAL which in turn is affected
by higher rate of SOCS-1 induction; slower rate of activation of
MAL being controlled by BTK.
The conditions (Table 1) for transition between these states
imply that, to avoid hyperinflammation, strategies should be
designed that: i) inhibit continuous activation of MAL by BTK, ii)
reduce the effect of high cytokine levels and iii) induce SOCS-1.
Our results suggest that under certain conditions, MAL related
inflammatory response in malaria patients, may cause hyperin-
flammation leading to CM. We hypothesize that constitutively
active BTK keeps activating MAL to produce the diseased
behavior and may be an important drug target. BTK, a tyrosine
kinase enzyme, is an attractive drug target and inhibitors are
already being developed against it for a number of diseases like B-
cell lymphomas and some autoimmune disorders [43].
The rate at which INCY are produced within the system is
crucial and will determine its fate [44]. These key divergence states
Table 3. Table of states, resources and logical parameters.
xx xy xz Qxx Qxy Qxz Kx(Qxx) Ky(xxy) Ky(Qxy)
0 00– } – } – } 000
00 1 fzg –} –} 1 0 0
0 10– } – } fyg 001
01 1 fzg –} fyg 101
1 00– } fxg – } 010
10 1 fzgf xg – } 110
1 10– } fxgf yg 011
11 1 fzgf xgf yg 111
This table lists all the states, set of resources and logical parameters of the BRN in Figure 2.
doi:10.1371/journal.pone.0033532.t003
Figure 6. A toy BRN. A toy example of a BRN where x, y and z
represent biological entities. The labels ‘+’ and ‘1’ represent the
activation and the threshold concentration respectively.
doi:10.1371/journal.pone.0033532.g006
Modeling and Analysis of the MAL-Associated BRN
PLoS ONE | www.plosone.org 9 March 2012 | Volume 7 | Issue 3 | e33532have INCY at level 1 and the system is at risk of going into the
diseased state if these levels are further increased. Individuals can
have high INCY levels due to various reasons which may include
genetic predisposition, repeated exposure to infectious agents or
chronic inflammatory conditions. Such conditions may partially
explain prevalence of CM in some Sub Saharan African
populations where malaria is endemic all year round and cytokine
levels are high due to asymptomatic parasitaemia [45–49]. The
effects of high cytokine levels may be controlled through the use of
anti-inflammatory agents. A recent study by Franklin et al., 2011
[50], emphasizes the relationship between elevated levels of
inflammatory cytokines and CM. They report a promising strategy
for the management of malarial severity by interfering with the
release of cytokines through inactivation of TLRs using antago-
nists. This supports our second hypothesis that suggests an
association between a preexisting high level of cytokines and the
progression of malaria towards CM. We suggest that such
individuals or population groups may be more susceptible to
develop CM and this opens up new avenues for future
investigations.
Conclusions
The normal (inflammatory) and abnormal behaviors (hyperin-
flammatory), presented by this qualitative model are consistent
with experimental observations. They are commonly observed
among population groups where in some the malarial infection is
Figure 7. State graph. The state graph of the BRN in Figure 3. Each
node represents a qualitative (discrete) state of the BRN. The values
inside a state represent the concentrations of the entities x, y and z.
doi:10.1371/journal.pone.0033532.g007
Figure 8. Snapshot of the MAL associated BRN construction in GENOTECH. The BRN is constructed as a directed graph by using the Gene’
New and Interaction’New menu options. An edge between two entities shows an interaction which is labeled with threshold and the sign of
interaction (+for activation and 2for degradation).
doi:10.1371/journal.pone.0033532.g008
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severe malaria (CM) may develop due to hyperinflammation.
This study suggests an association between pre-existing high
cytokine levels and progression of malaria towards CM, and opens
up new avenues of investigation. This means that screening
population groups, in areas where CM is endemic, for inflamma-
tory cytokine levels may help identify ‘at risk’ individuals. This can
be used as a predictive indicator that such an individual may
progress towards CM. Multiple strategies that interfere with the
TLR signal transduction, e.g. the use of BTK inhibitors and
antinflammatory agents along with existing treatments should be
further explored.
This study also shows that formal methods can support BRN
modeling, which in turn facilitates state space exploration and
trajectory computation. In future we plan to conduct the formal
probabilistic analysis [51] to gain more insight into the MAL
signaling network.
Materials and Methods
Qualitative modeling
Biological systems are traditionally modelled with ordinary
differential equations that refer to the time derivative of each
quantity (concentration, rates and temperature etc.). Due to the
inherent complexity of biological systems, the exact amounts of
these quantities are rarely known. In 1970, Rene ´ Thomas [38]
introduced a Boolean logic based method for the modeling of
biological regulatory networks in which the system dynamics are
modelled qualitatively. He proved the effectiveness of his modeling
approach by analyzing the lambda phage genetic switch [38,52–
55]. Accordingto Rene ´ Thomas, the Boolean modeling suffers from
some limitations because it has only two levels, 0 or 1, which are not
sufficient to formalize all kinds of relevant problems. Later on,
Thomas generalized the Boolean logic to ‘kinetic logic’ [28–36] and
showed its practical effectiveness by applying it to different genetic
regulatory systems. An interesting feature of ‘kinetic logic’ is that it
closelyapproximates the differential equations based modeling [29].
The Kinetic Logic formalism of Rene ´ Thomas
The kinetic logic formalism models BRNs by focussing on
threshold effects. The entities (usually proteins) of biological
systems can interact with each other either positively or negatively;
that is the concentration level of one element can increase or
decrease the rate of activation of other elements. In our setting
activation means production of a particular protein, if it is absent,
or its activation from an inactive state. Similarly, inactivation
Figure 9. Snapshot of the logical parameters. Each entity of the BRN is assigned a set of logical parameters by using the properties option
accessible by right clicking that entity.
doi:10.1371/journal.pone.0033532.g009
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Following are the two types of biological regulation which are of
sigmoid (nonlinear bounded curve) nature.
Activation
If a product a increases the rate of activation of product b,i ti sa
positive regulator. In this situation the rate of activation of b
increases with increasing concentration of a , which can be
depicted by a sigmoidal representation as shown in Figure 5. It can
be seen that there is little effect of a on the rate of activation of b
for as long as it remains below a given threshold, h. Once a
reaches this threshold, the rate of activation of b increases rapidly
until b is saturated. In other words we can say that a was ‘inactive’
when avh and ‘active’ for a§h, this suggests the approximation
of the sigmoidal curve by a step function as shown in Figure 5(A.).
Inhibition
If product a reduces the rate of activation of product b,i ti s
called a negative regulator or inhibitor. The effect of this negative
regulation or inhibition is shown in Figure 5(B.).
Semantics of the Kinetic Logic Formalism
This section presents the semantics of Thomas’s formalism with
a hypothetical running example of a gene regulatory network
involving three genes (x, y and z).
Definition 1 (Directed Graph). A directed graph is an ordered
pair G(N,E), where
N N is the set of all nodes and
N E(N|N is the set of ordered pairs called edges or arcs
An edge (a,b) is considered to be directed from a to b; a is called
the head and b is called the tail of the edge. In a directed graph
G(N,E), G{(x) and Gz(x) denote the set of predecessors and
successors of a node x[N, respectively.
Figure 6 shows a network represented by a directed graph
showing the genes in which N~fx,y,zg and E~f(x,y),
(y,z),(z,x)g are the sets of nodes and edges, respectively. In case
of gene x, (The set of regulators of x) G{(x)~fzg and
Gz(x)=fyg represents the predecessors and successors of x.
Definition 2 (Biological Regulatory Network). A biological
regulatory network (BRN) is a labeled directed graph G(N,E), where N is a
Figure 10. Snapshot of the state graph in GENOTECH. The stable states are highlighted in red. The right panel shows the analysis command
which include: show path which highlights paths between two selected states; show cycle which highlights existing cycles (closed path), if any, in the
state graph; show neighboring states highlights all the neighboring states of the selected state. The conversion menu contains the commands to
export the graph to DOT and HyTech formats.
doi:10.1371/journal.pone.0033532.g010
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possible edges which represent the interaction between entities.
N Each edge x?y is labeled by a pair (jxy,gxy), where jxy is
positive integer (qualitative level representing a threshold) and
gxy is either the (+) sign or the (2) sign, where (+) represents
activation and (2) inhibition. For an example see Figure 6,
where jxy~1, jyz~1, jzx~1 and similarly gxy~z, gyz~z,
gzx~z.
N Each node x has a limit px, which is equal to out-degree of x
(the total number of targets of x), such that Vy[Gz(x) each
jxy[f1,2,::::,rxg where rxƒpx.
N Each entity x has its abstract concentration in the set
Zx~f0,1,::::,rxg.
It is important to consider the possible number of states and
transitions between them to understand the behavior of the BRN.
Definition 3 (States). Let G be a BRN. The state of a BRN is a
tuple s[S, where
S~Pa[NZa
The qualitative states are represented by vector (sxa)Va[N, where
xa denotes the level of concentration of product a. A qualitative
state represents a configuration of all the elements of a BRN at any
instant of time. The number of activators of a particular variable at
a given level of concentration are represented by its set of resources
(see the definition of Resources given below). In the following
definition, we formally define the set of resources which represents
all the activators of an entity at any instance of time.
Definition 4 (Resources). Let G be a BRN. The set of resources
Qxa of a variable a[N at a level x is defined as Qxa =fb[G{(a)D
(xb§jba and gba~z) or (xbvjba and gba~{)g.
The dynamic behaviors of BRN depends on logical parameters.
The set of these logical parameters is defined as
K(G)~fKa(Qxa)[ZaVa[Ng.
The parameter Ka(Qxa) ( a tal e v e lx of a) gives the information
about the evolution of x. There are three cases: 1) if xavKa(Qxa) then
xa increases by one unit, 2) if xawKa(Qxa) then xa decreases by one
unit, and 3), if xa~Ka(Qxa) then xa cannot evolve from its current
level. In case of the running example of three genes (Figure 6), the set of
resources and logical parameters are shown in Table 3.
It is convenient to describe the evolution from one level to the
other by an evolution operator [56], which is defined as follows:
xa Ka(Qxa)~
xaz1 if xa v Ka(Qxa);
xa{1 if xa w Ka(Qxa);
xa if xa ~ Ka(Qxa):
8
> <
> :
where xa and Ka(Qxa)[Z§0
Definition 5 (State Graph). Let G be a BRN and sxa represents
the concentration level of entity a in a state s[S. Then the state graph of the
BRN will be the directed graph G~(S,T) , where S is set of states and
T(S|S represents a relation between states, called the transition relation,
such that s?s’[T if and only if:
1. A a unique aeN such that sxa=sxa
0 and sxa
0~sxa Ka(Qxa), and
2. V beN\fagsxb
0~sxb.
From the table of resources (Table 3), interesting information
regarding its dynamic behavior can be derived, c.f. Figure 7. It is
clear from the state graph that there are two stable states, namely
(000) and (111).
Discrete Modeling of MAL associated BRN using
GENOTECH
GENOTECH [26] facilitates modeling of BRNs according to
Thomas’ formalism. It takes a BRN and the corresponding logical
parameters form a user in a simple graphical user interface (GUI).
It automatically produces the whole state space in which stable
states, cycles and paths between any two states can be identified.
The software tool GINsim (Gene Interaction Network simulation)
[57] could also be used for the qualitative modeling and analysis of
BRNs. GENOTECH is available for download at http://code.
google.com/p/genotech/downloads/list and the following step
are required for modeling a BRN in GENOTECH.
1. Construction of a BRN as a labeled directed graph: The GUI
of GENOTECH provides a set of commands to create, edit
and save a BRN. The two drop down menus Gene and
Interaction are used to construct the nodes and edges of a BRN
respectively; and each biological entity is assigned a set of
logical parameters (see Figure 8 and 9).
2. Generation of a state graph: After the construction of the BRN,
a state graph can be generated by using the command state
graph in the File menu. The state graph, showing stable states
in red, appears in a new window with its own set of commands
to find cycles, paths between two states, and neighboring states
(see Figure 10). GENOTECH also provides an option to save
the state graph in DOT format [58] for visualization in
Graphviz tool [59].
Figure 11. Timing diagram. Timing diagram showing the evolution
of proteins involved in BRN. Here the concentrations are represented by
two levels x and x+1 on the vertical axis. The horizontal axis represent
the time of evolution. The dotted lines are the boundaries of the
different configurations of the discrete concentrations. Each configu-
ration is according to the order (BTK , MAL, NF-kB, INCY, SOCS-1).
doi:10.1371/journal.pone.0033532.g011
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number of entities, their interactions, thresholds and logical
parameters. In order to make this method more scalable, a
simplification technique based on the coloration method, which
extracts the desirable parts of the state graph, has been proposed in
our previous work [60] – the future versions of GENOTECH will
implement this technique.
Figure 1 shows the TLR2/4 molecular pathway adapted from
literature [15,24,25]. The MAL associated BRN was abstracted
from this pathway and is shown in Figure 2. The Network flow is
as follows: BTK activates MAL and MAL activates NF-kB after
reaching threshold level of 1; INCY are activated by NF-kBa ta
threshold level of 1; there are two interactions of INCY which are
the activations of SOCS-1 and NF-kB at level 1 and level 2
respectively; and SOCS-1 inhibits MAL and NF-kB at threshold
level 1. Using the Thomas’ formalism presented in the previous
section, preliminary insilico experiments were performed to set the
threshold orders and to determine the values of logical parameters
(see Figure 3) in order to make the model consistent with naturally
observed behaviors (steady states).
Hybrid modeling to enhance the discrete modeling with
delays
A hybrid model of a BRN involves discrete locations associated
with some continuous variables (clocks). The continuous transi-
tions represent time that elapses in a location, whereas discrete
transitions show the instantaneous change between locations [61].
The timing diagram of one normal path is shown in Figure 11. It
depicts proteins evolving from one level to another (from x to x+1
or x+1 to x) in a discrete fashion (Figure 12). In reality, however,
the concentrations of these proteins evolve in a nonlinear and
continuous manner and this behavior cannot be represented in a
discrete modeling framework. Various formalisms [62,63] have
been proposed for biological modeling to overcome this limitation
of discrete modeling. Ahmad et al. [64] proposed the refinement of
discrete modeling by hybrid modeling, where sigmoidal nature
evolutions are modelled with piecewise linear curves. This
contrasts discrete modeling, in which these evolutions are
modelled using step functions (Figure 12). Considering that a
delay is required for the evolution of a protein from level x to
xz1, or from xz1 to x, it is important to introduce some
additional concepts, namely time intervals and clocks.
The approach of Siebert and Bockmayr [63] is similar to our
approach. The authors incorporate time delays in the logical
formalism of Rene ´ Thomas using timed automaton [65] which is a
more restrictively expressive model than hybrid automaton, since
it does not deal with non-increasing variables.
Clocks are continuous variables used in timed automaton based
models [65], which are a subclass of hybrid automata [66]. Each
protein is associated with a clock variable h that synchronously
evolves with time. These clock intervals reflect the characteristics
of continuous dynamics within the available discrete formalism
[61,64]. The time measured by the clock variable h between two
levels is called the delay between these levels. The initial value of
the clock variable is set to zero and when the value of this clock
variable is equal to delay time d
z or d
{ the transition between
Figure 12. Different representations of the evolution of an entity. Evolutions of an entity a is shown as: sigmoidal representation of the
activation (A.), discrete approximation of the activation (B.), piece-wise linear approximation of the activation (C.), sigmoidal representation of the
degradation (D.), discrete approximation of the degradation (E.) and piece-wise linear approximation of the degradation (F.).
doi:10.1371/journal.pone.0033532.g012
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{ represents time taken
from x to xz1 (positive delay or production delay) or xz1 to x
(negative delay or degradation delay), respectively (Figure 12). The
speed by which the clock variables h evolve is modelled by the first
order derivatives dh=dt~r, where r lies in the set f0,1g. This value
characterizes the evolution of the associated variable, which
normally represents the concentration level of a protein [61,64].
We thus obtain a hybrid model that is suitable to represent the
discrete and continuous dynamics of the systems that we consider.
In this work, delays are considered as unvalued parameters, which
motivate the introduction of Parametric Bio Linear Hybrid
Automata (Bio-LHA) for the modeling of the MAL associated
BRN, as presented in the next subsection.
Parametric Bio-LHA
Parametric Bio-LHA was originally proposed by Ahmad et al.
[26] for the linear hybrid modeling of BRN. This framework
refines the discrete (qualitative) model by incorporating clocks and
time delays in it. The resultant model is then suitable for the
computation of exact conditions in the form of delay constraints
for the existence of the behaviors of BRN.
Let C~(X,P) (resp. Cƒ(X,P)) be the set of constraints using
only ~ (resp. ƒ) where X and P are the sets of real valued
variables and parameters respectively.
Definition 6 (Parametric Bio-LHA). A parametric Bio-LHA
H is a tuple (L,l0,X,P,E,Inv,Dif) where
N L is a finite set of locations.
N l0[L is the initial location.
N P is a finite set of parameters (delays).
N X is a finite set real-valued variables (clocks).
N E(L|C~(X,P)|2X|L is a finite set of edges,e~(l,g,R,l’)[E
represents an edge from the location l to the location l’ with the
guard g and the reset set R(X; we require that the set of clocks in
g is a subset of R.
N Inv : L?Cƒ(X,P) assigns an invariant to any location.
N Dif : L|X?f0,1g maps each pair (l,h) to an evolution rate.
The semantics of a parametric Bio-LHA is a timed transition
system. We define the semantics according to the time domain T.
We let T
 ~T\f0g.
Definition 7 (Semantics of Bio-LHA). Let c be a valuation for
the parameters P and n represents the values of clocks in a location. The
(T,c)-semantics of a parametric Bio-LHA H~(L,‘0,X,P,E,Inv,Dif) is
defined as a timed transition system SH~(S,s0,T,?) where: (1)
S~f(‘,n) D‘[Landn   Inv(‘)g; (2) s0 is the initial state and (3) the
relation ?(S|T|S is defined for t[T as:
N discrete transitions: (‘,n)
0 (‘’,n’) iff A(‘,g,R,‘’)[E such that
g(n)~true, n’(h)~0 if h[R and n’(h)~n(h) if h = [R.
N continuous transitions: For t[T
 , (‘,n)
t (‘’,n’) iff ‘’~‘, n’(h)~
n(h)zDif(‘,h)|t,a n df o re v e r yt’[½0,t , (n(h)zDif(‘,h)|
t’)   Inv(‘).
The partial Bio-LHA of the MAL associated BRN is shown in
Figure 13. For the sake of simplicity, only three locations are
considered in this model. The inequalities, such as (hBTKƒd
{
BTK),
represent invariants or the stay conditions for the BRN to remain
in a particular configuration (location). For example,
(hBTKƒd
{
BTK) requires that the clock variable hBTK of BTK
should be less than or equal to the degradation delay (time
required to change level xz1 to x ) of BTK.
The rate dhBTK (HyTech representation of dhBTK/dt)
provides an indication about the evolution from one level to
another. The clock variables hi (i-th protein) measure the time
taken by associated proteins in a particular level, and clocks are set
to zero once the transition has occurred. The complete Bio-LHA
involves forty eight locations and five clock variables associated
with each protein involved in the BRN (Figure 2).
The next section presents the investigation of causality
conditions for the normal and the divergent behaviors.
Synthesis of delay parameters using HyTech: A Linear
Hybrid Model checking approach
In this study, a Bio-LHA was used for the hybrid modeling of
the MAL associated BRN. As discussed above, the unvalued
delays represent parameters in the Bio-LHA. In order to analyze
this model, the linear hybrid model checking tool HyTech was
used, which is widely applied to the modeling and verification of
hybrid systems. The main motivation for using HyTech for the
analysis of this class of systems is its very rich set of analysis
commands as well as the parameter synthesis capabilities of this
tool (Table 1 and 2).
Figure 13. Bio-LHA. Partial view of Bio-LHA of the MAL associated
BRN. The labels 11000, 01000 and 11100 shows the state (configuration)
of BRN consisting of five entities (BTK, MAL, NF-kB, INCY, SOCS-1).
doi:10.1371/journal.pone.0033532.g013
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